15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Xp Inc, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $25.00 to $25.00, so the covering firms are broadly aligned. The average target of $25.00 sits 49% above the current $16.81. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.71 next quarter toward $11.95 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Strong Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Xp Inc.
As of Jul, 3 of 3 firms rate XP a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
XP EPS & revenue forecast
EPS · NEXT QUARTER
$2.71
Range $2.66 – $2.74 · 4 analysts · +10% YoY
Next period, 4 analysts expect Xp Inc to earn $2.71 a share (range $2.66 – $2.74), versus $2.47 a year earlier. Full-year consensus is $10.66, growing to $11.95 the year after.
REVENUE · NEXT QUARTER
$5.0B
Range $4.9B – $5.1B · 4 analysts · +8% YoY
Revenue is expected to reach $5.0B (range $4.9B – $5.1B), +7.6% year-over-year. Full-year consensus is $20.1B, rising to $22.6B next year.
Top analysts covering Xp Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XP.
#1
TB
Thiago Batista
UBS
Buy
$25.00+48.7% to target
Coverage
—
+ Follow
#2
JK
Jorge Kuri
Morgan Stanley
Buy
$26.00+54.7% to target
Coverage
—
+ Follow
#3
GS
Gustavo Schroden
Citigroup
Buy
$23.00+36.8% to target
Coverage
—
+ Follow
#4
PL
Pedro Leduc
Itau Unibanco
Hold
$21.00+24.9% to target
Coverage
—
+ Follow
#5
HN
Henrique Navarro
Banco Santander
Buy
$22.00+30.9% to target
Coverage
—
+ Follow
XP stock forecast FAQ
What is XP's average 12-month price target?+
The 1 analysts with a live target average $25.00 for Xp Inc over the next 12 months, ranging from a $25.00 high to a $25.00 low.
Is XP stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover XP?+
3 analysts have an active rating on Xp Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering XP?+
Among analysts who currently cover XP, Thiago Batista of UBS has the strongest overall Quantellect track record. Their current call is Buy with a $25.00 target.
What is Xp Inc's projected EPS for next quarter?+
The consensus estimate is $2.71 per share (range $2.66 – $2.74) across 4 analysts. Full-year EPS is projected at $10.66, rising to $11.95 the following year.
How much revenue is Xp Inc expected to report next quarter?+
Consensus revenue is $5.0B (range $4.9B – $5.1B). Full-year revenue is projected at $20.1B, growing to $22.6B next year.
Have analysts been upgrading or downgrading XP lately?+
As of Jul, 3 of 3 firms rate XP a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
